 | • レポートコード：MRC2-11QY01543 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はイマチニブ薬のグローバル市場について調査・分析したレポートです。種類別（カプセル、錠剤）市場規模、用途別（病院、ドラッグストア、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別イマチニブ薬の競争状況、市場シェア ・世界のイマチニブ薬市場：種類別市場規模 2015年-2020年（カプセル、錠剤） ・世界のイマチニブ薬市場：種類別市場規模予測 2021年-2026年（カプセル、錠剤） ・世界のイマチニブ薬市場：用途別市場規模 2015年-2020年（病院、ドラッグストア、その他） ・世界のイマチニブ薬市場：用途別市場規模予測 2021年-2026年（病院、ドラッグストア、その他） ・北米のイマチニブ薬市場分析：米国、カナダ ・ヨーロッパのイマチニブ薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのイマチニブ薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のイマチニブ薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのイマチニブ薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Apotex Inc.、Novartis、Sanofi S.A.、Cipla Inc.、Mylan Pharms Inc.、Glenmark Pharmaceuticals Ltd.、Sun Pharmaceuticals、Actavis Generics、Dr. Reddy's Laboratories、Teva Pharmaceutical Industries Ltd. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Imatinib Drugs Market
The global Imatinib Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Imatinib Drugs Scope and Market Size
Imatinib Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Imatinib Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Imatinib Drugs market is segmented into
Capsules
Tablets
Segment by Application, the Imatinib Drugs market is segmented into
Hospitals
Drug Stores
Other
Regional and Country-level Analysis
The Imatinib Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Imatinib Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Imatinib Drugs Market Share Analysis
Imatinib Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Imatinib Drugs business, the date to enter into the Imatinib Drugs market, Imatinib Drugs product introduction, recent developments, etc.
The major vendors covered:
Apotex Inc.
Novartis
Sanofi S.A.
Cipla Inc.
Mylan Pharms Inc.
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy’s Laboratories
Teva Pharmaceutical Industries Ltd.
1 Study Coverage
1.1 Imatinib Drugs Product Introduction
1.2 Market Segments
1.3 Key Imatinib Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Imatinib Drugs Market Size Growth Rate by Type
1.4.2 Capsules
1.4.3 Tablets
1.5 Market by Application
1.5.1 Global Imatinib Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Drug Stores
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Imatinib Drugs Market Size, Estimates and Forecasts
2.1.1 Global Imatinib Drugs Revenue 2015-2026
2.1.2 Global Imatinib Drugs Sales 2015-2026
2.2 Global Imatinib Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Imatinib Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Imatinib Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Imatinib Drugs Competitor Landscape by Players
3.1 Imatinib Drugs Sales by Manufacturers
3.1.1 Imatinib Drugs Sales by Manufacturers (2015-2020)
3.1.2 Imatinib Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Imatinib Drugs Revenue by Manufacturers
3.2.1 Imatinib Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Imatinib Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Imatinib Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Imatinib Drugs Revenue in 2019
3.2.5 Global Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Imatinib Drugs Price by Manufacturers
3.4 Imatinib Drugs Manufacturing Base Distribution, Product Types
3.4.1 Imatinib Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Imatinib Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Imatinib Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Imatinib Drugs Market Size by Type (2015-2020)
4.1.1 Global Imatinib Drugs Sales by Type (2015-2020)
4.1.2 Global Imatinib Drugs Revenue by Type (2015-2020)
4.1.3 Imatinib Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Imatinib Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Imatinib Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Imatinib Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Imatinib Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Imatinib Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Imatinib Drugs Market Size by Application (2015-2020)
5.1.1 Global Imatinib Drugs Sales by Application (2015-2020)
5.1.2 Global Imatinib Drugs Revenue by Application (2015-2020)
5.1.3 Imatinib Drugs Price by Application (2015-2020)
5.2 Imatinib Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Imatinib Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Imatinib Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Imatinib Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Imatinib Drugs by Country
6.1.1 North America Imatinib Drugs Sales by Country
6.1.2 North America Imatinib Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Imatinib Drugs Market Facts & Figures by Type
6.3 North America Imatinib Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Imatinib Drugs by Country
7.1.1 Europe Imatinib Drugs Sales by Country
7.1.2 Europe Imatinib Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Imatinib Drugs Market Facts & Figures by Type
7.3 Europe Imatinib Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Imatinib Drugs by Region
8.1.1 Asia Pacific Imatinib Drugs Sales by Region
8.1.2 Asia Pacific Imatinib Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Imatinib Drugs Market Facts & Figures by Type
8.3 Asia Pacific Imatinib Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Imatinib Drugs by Country
9.1.1 Latin America Imatinib Drugs Sales by Country
9.1.2 Latin America Imatinib Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Imatinib Drugs Market Facts & Figures by Type
9.3 Central & South America Imatinib Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Imatinib Drugs by Country
10.1.1 Middle East and Africa Imatinib Drugs Sales by Country
10.1.2 Middle East and Africa Imatinib Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Imatinib Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Imatinib Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Apotex Inc.
11.1.1 Apotex Inc. Corporation Information
11.1.2 Apotex Inc. Description and Business Overview
11.1.3 Apotex Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Apotex Inc. Imatinib Drugs Products Offered
11.1.5 Apotex Inc. Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Imatinib Drugs Products Offered
11.2.5 Novartis Related Developments
11.3 Sanofi S.A.
11.3.1 Sanofi S.A. Corporation Information
11.3.2 Sanofi S.A. Description and Business Overview
11.3.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi S.A. Imatinib Drugs Products Offered
11.3.5 Sanofi S.A. Related Developments
11.4 Cipla Inc.
11.4.1 Cipla Inc. Corporation Information
11.4.2 Cipla Inc. Description and Business Overview
11.4.3 Cipla Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Cipla Inc. Imatinib Drugs Products Offered
11.4.5 Cipla Inc. Related Developments
11.5 Mylan Pharms Inc.
11.5.1 Mylan Pharms Inc. Corporation Information
11.5.2 Mylan Pharms Inc. Description and Business Overview
11.5.3 Mylan Pharms Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Pharms Inc. Imatinib Drugs Products Offered
11.5.5 Mylan Pharms Inc. Related Developments
11.6 Glenmark Pharmaceuticals Ltd.
11.6.1 Glenmark Pharmaceuticals Ltd. Corporation Information
11.6.2 Glenmark Pharmaceuticals Ltd. Description and Business Overview
11.6.3 Glenmark Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Products Offered
11.6.5 Glenmark Pharmaceuticals Ltd. Related Developments
11.7 Sun Pharmaceuticals
11.7.1 Sun Pharmaceuticals Corporation Information
11.7.2 Sun Pharmaceuticals Description and Business Overview
11.7.3 Sun Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sun Pharmaceuticals Imatinib Drugs Products Offered
11.7.5 Sun Pharmaceuticals Related Developments
11.8 Actavis Generics
11.8.1 Actavis Generics Corporation Information
11.8.2 Actavis Generics Description and Business Overview
11.8.3 Actavis Generics Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Actavis Generics Imatinib Drugs Products Offered
11.8.5 Actavis Generics Related Developments
11.9 Dr. Reddy’s Laboratories
11.9.1 Dr. Reddy’s Laboratories Corporation Information
11.9.2 Dr. Reddy’s Laboratories Description and Business Overview
11.9.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Dr. Reddy’s Laboratories Imatinib Drugs Products Offered
11.9.5 Dr. Reddy’s Laboratories Related Developments
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Corporation Information
11.10.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Products Offered
11.10.5 Teva Pharmaceutical Industries Ltd. Related Developments
11.1 Apotex Inc.
11.1.1 Apotex Inc. Corporation Information
11.1.2 Apotex Inc. Description and Business Overview
11.1.3 Apotex Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Apotex Inc. Imatinib Drugs Products Offered
11.1.5 Apotex Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Imatinib Drugs Market Estimates and Projections by Region
12.1.1 Global Imatinib Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Imatinib Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Imatinib Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Imatinib Drugs Sales Forecast (2021-2026)
12.2.2 North America: Imatinib Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Imatinib Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Imatinib Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Imatinib Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Imatinib Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Imatinib Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Imatinib Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Imatinib Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Imatinib Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Imatinib Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Imatinib Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Imatinib Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Imatinib Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Imatinib Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Imatinib Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Imatinib Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Imatinib Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Imatinib Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Imatinib Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Imatinib Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Imatinib Drugs Market Segments
Table 2. Ranking of Global Top Imatinib Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Imatinib Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Capsules
Table 5. Major Manufacturers of Tablets
Table 6. Global Imatinib Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Imatinib Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Imatinib Drugs Sales by Regions 2015-2020 (K MT)
Table 9. Global Imatinib Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Imatinib Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Imatinib Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Imatinib Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Imatinib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Imatinib Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Imatinib Drugs as of 2019)
Table 15. Imatinib Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Imatinib Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Imatinib Drugs Price (2015-2020) (USD/MT)
Table 18. Imatinib Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Imatinib Drugs Product Type
Table 20. Date of International Manufacturers Enter into Imatinib Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Imatinib Drugs Sales by Type (2015-2020) (K MT)
Table 23. Global Imatinib Drugs Sales Share by Type (2015-2020)
Table 24. Global Imatinib Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Imatinib Drugs Revenue Share by Type (2015-2020)
Table 26. Imatinib Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Imatinib Drugs Sales by Application (2015-2020) (K MT)
Table 28. Global Imatinib Drugs Sales Share by Application (2015-2020)
Table 29. North America Imatinib Drugs Sales by Country (2015-2020) (K MT)
Table 30. North America Imatinib Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Imatinib Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Imatinib Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Imatinib Drugs Sales by Type (2015-2020) (K MT)
Table 34. North America Imatinib Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Imatinib Drugs Sales by Application (2015-2020) (K MT)
Table 36. North America Imatinib Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Imatinib Drugs Sales by Country (2015-2020) (K MT)
Table 38. Europe Imatinib Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Imatinib Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Imatinib Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Imatinib Drugs Sales by Type (2015-2020) (K MT)
Table 42. Europe Imatinib Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Imatinib Drugs Sales by Application (2015-2020) (K MT)
Table 44. Europe Imatinib Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Imatinib Drugs Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Imatinib Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Imatinib Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Imatinib Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Imatinib Drugs Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Imatinib Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Imatinib Drugs Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Imatinib Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Imatinib Drugs Sales by Country (2015-2020) (K MT)
Table 54. Latin America Imatinib Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Imatinib Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Imatinib Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Imatinib Drugs Sales by Type (2015-2020) (K MT)
Table 58. Latin America Imatinib Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Imatinib Drugs Sales by Application (2015-2020) (K MT)
Table 60. Latin America Imatinib Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Imatinib Drugs Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Imatinib Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Imatinib Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Imatinib Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Imatinib Drugs Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Imatinib Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Imatinib Drugs Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Imatinib Drugs Sales Market Share by Application (2015-2020)
Table 69. Apotex Inc. Corporation Information
Table 70. Apotex Inc. Description and Major Businesses
Table 71. Apotex Inc. Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Apotex Inc. Product
Table 73. Apotex Inc. Recent Development
Table 74. Novartis Corporation Information
Table 75. Novartis Description and Major Businesses
Table 76. Novartis Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Novartis Product
Table 78. Novartis Recent Development
Table 79. Sanofi S.A. Corporation Information
Table 80. Sanofi S.A. Description and Major Businesses
Table 81. Sanofi S.A. Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Sanofi S.A. Product
Table 83. Sanofi S.A. Recent Development
Table 84. Cipla Inc. Corporation Information
Table 85. Cipla Inc. Description and Major Businesses
Table 86. Cipla Inc. Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Cipla Inc. Product
Table 88. Cipla Inc. Recent Development
Table 89. Mylan Pharms Inc. Corporation Information
Table 90. Mylan Pharms Inc. Description and Major Businesses
Table 91. Mylan Pharms Inc. Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Mylan Pharms Inc. Product
Table 93. Mylan Pharms Inc. Recent Development
Table 94. Glenmark Pharmaceuticals Ltd. Corporation Information
Table 95. Glenmark Pharmaceuticals Ltd. Description and Major Businesses
Table 96. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Glenmark Pharmaceuticals Ltd. Product
Table 98. Glenmark Pharmaceuticals Ltd. Recent Development
Table 99. Sun Pharmaceuticals Corporation Information
Table 100. Sun Pharmaceuticals Description and Major Businesses
Table 101. Sun Pharmaceuticals Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Sun Pharmaceuticals Product
Table 103. Sun Pharmaceuticals Recent Development
Table 104. Actavis Generics Corporation Information
Table 105. Actavis Generics Description and Major Businesses
Table 106. Actavis Generics Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Actavis Generics Product
Table 108. Actavis Generics Recent Development
Table 109. Dr. Reddy's Laboratories Corporation Information
Table 110. Dr. Reddy's Laboratories Description and Major Businesses
Table 111. Dr. Reddy's Laboratories Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Dr. Reddy's Laboratories Product
Table 113. Dr. Reddy's Laboratories Recent Development
Table 114. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 115. Teva Pharmaceutical Industries Ltd. Description and Major Businesses
Table 116. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Teva Pharmaceutical Industries Ltd. Product
Table 118. Teva Pharmaceutical Industries Ltd. Recent Development
Table 119. Global Imatinib Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 120. Global Imatinib Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Imatinib Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Imatinib Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Imatinib Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 124. North America: Imatinib Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Imatinib Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 126. Europe: Imatinib Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Imatinib Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 128. Asia Pacific: Imatinib Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Imatinib Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 130. Latin America: Imatinib Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Imatinib Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 132. Middle East and Africa: Imatinib Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Imatinib Drugs Players
Table 137. Imatinib Drugs Customers List
Table 138. Imatinib Drugs Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Imatinib Drugs Product Picture
Figure 2. Global Imatinib Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Capsules Product Picture
Figure 4. Tablets Product Picture
Figure 5. Global Imatinib Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Drug Stores
Figure 8. Other
Figure 9. Imatinib Drugs Report Years Considered
Figure 10. Global Imatinib Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Imatinib Drugs Sales 2015-2026 (K MT)
Figure 12. Global Imatinib Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Imatinib Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Imatinib Drugs Sales Market Share by Region in 2019
Figure 15. Global Imatinib Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Imatinib Drugs Revenue Market Share by Region in 2019
Figure 17. Global Imatinib Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Imatinib Drugs Revenue in 2019
Figure 19. Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Imatinib Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Imatinib Drugs Sales Market Share by Type in 2019
Figure 22. Global Imatinib Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Imatinib Drugs Revenue Market Share by Type in 2019
Figure 24. Global Imatinib Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Imatinib Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Imatinib Drugs Sales Market Share by Application in 2019
Figure 27. Global Imatinib Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Imatinib Drugs Revenue Market Share by Application in 2019
Figure 29. North America Imatinib Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Imatinib Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Imatinib Drugs Sales Market Share by Country in 2019
Figure 32. North America Imatinib Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Imatinib Drugs Market Share by Type in 2019
Figure 38. North America Imatinib Drugs Market Share by Application in 2019
Figure 39. Europe Imatinib Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Imatinib Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Imatinib Drugs Sales Market Share by Country in 2019
Figure 42. Europe Imatinib Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Imatinib Drugs Market Share by Type in 2019
Figure 54. Europe Imatinib Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Imatinib Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Imatinib Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Imatinib Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Imatinib Drugs Revenue Market Share by Region in 2019
Figure 59. China Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Imatinib Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Imatinib Drugs Market Share by Application in 2019
Figure 83. Latin America Imatinib Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Imatinib Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Imatinib Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Imatinib Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Imatinib Drugs Market Share by Type in 2019
Figure 94. Latin America Imatinib Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Imatinib Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Imatinib Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Imatinib Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Imatinib Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Imatinib Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Imatinib Drugs Market Share by Application in 2019
Figure 107. North America Imatinib Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Imatinib Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Imatinib Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Imatinib Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Imatinib Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Imatinib Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Imatinib Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Imatinib Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Imatinib Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Imatinib Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
胃がん治療薬の世界市場（～2026年） Gastric cancer drugs are used to treat malignancies, or cancerous growths. The APAC region to account for the highest market share during the forecast period. Much of this region’s growth can be attributed to the increasing demand for better healthcare infrastructure, which results in its massive ma…- 植物・植物由来薬剤の世界市場（～2026年） Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- テネクテプラーゼ薬の世界市場（～2026年） Tenecteplase drug is an enzyme derived through recombinant DNA technology from a human cell line. This enzyme is used to treat thrombus (blood clots) it is also called as clot-busting drug. Tenecteplase is a bioengineered variant of the activase drug. It is estimated that North America dominated the…
- 自己免疫治療薬の世界市場（～2026年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…